Microbiome science to improve women’s health

9, 10 & 11 April 2024 | Copenhagen, Denmark

Presented by

Committee

Acting Director, Institute for Genome Sciences

Professor of Microbiology and Immunology, University of Maryland School of Medicine

Ina Schuppe Koistinen

Jacques Ravel

Alliance Director Centre of Translational Microbiome Research

Karolinska Institutet

Kelle Moley

Vanessa K. Ridaura

Global VP of Clinical and Translational R&D, Reproductive Medicine and Maternal Health

Ferring Pharmaceuticals

Senior Program Officer - Microbiome Products

Bill & Melinda Gates Foundation

Niels Thun Andersen

Head of Life Science Team

Copenhagen Capacity

Director of Science - Future Labs

Chr. Hansen

Johan E.T. van Hylckama Vlieg

Adam Baker

CSO and Co-founder

Freya Biosciences

Women's health is an area of medicine that has historically been under-researched and under-funded. However, there has been growing recognition of the unmet need for research and treatments in this field. Microbiome research has shown promise in addressing some of these unmet needs. From the vaginal microbiome in reproductive health to the impact of menopause on the skin microbiome, the applications of microbiome science in women’s health are wide reaching and present an opportunity to develop novel therapeutic approaches and diagnostics.

Join us in Copenhagen for the first annual "Microbiomes in Women's Health Congress," where world-leading microbiome researchers, cutting-edge biotechs, and healthcare and pharmaceutical voices will unite to present their work on how the microbiome can be used to improve women's health.

The event will be split into chronological stages across a woman’s life spanning sessions on: exploring what is a typical vaginal microbiome, fertility, pregnancy, menopause, women-specific indications, and the development of therapeutics.

Sponsors 2024